权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Structural studies of amyloid beta globulomers with EPR spectroscopy

利用 EPR 光谱法研究淀粉样蛋白球聚体的结构

基本信息

批准号：
9899173
负责人：
Zhefeng Guo
金额：
$ 39万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-07-15 至 2022-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9899173
关键词：
Age Alzheimer&apos s Disease Alzheimer&apos s disease risk Amyloid Amyloid Fibrils Amyloid beta-42 Amyloid beta-Protein Architecture Data Dementia Disease Docking Drug Design Electron Spin Resonance Spectroscopy Electrons Functional disorder Goals Healthcare Healthcare Systems Heterogeneity Huntington Disease Knowledge Light Longevity Measurement Measures Modeling Mutagenesis Neurodegenerative Disorders Neurotoxins Non-Insulin-Dependent Diabetes Mellitus Pain Parkinson Disease Pathogenesis Pharmaceutical Preparations Positioning Attribute Prevalence Protein Isoforms Proteins Public Health Publishing Research Resolution Scanning Site Site-Directed Mutagenesis Spin Labels Structural Models Structure Synapses System Techniques Time Validation abeta accumulation abeta oligomer abeta toxicity alpha helix base beta pleated sheet design drug development exhaustion human disease human very old age (85+)insight intermolecular interaction mutant nanosecond neuron loss neurotoxicity programs protein structure prediction success

项目摘要

Project Summary/Abstract Alzheimer’s disease, the major cause of dementia, is a fatal neurodegenerative disorder. The primary risk factor for Alzheimer’s disease is age. The prevalence of Alzheimer’s disease increases dramatically when people reach 65 years or older, reaching nearly 50% for people of >85 years old. Therefore, Alzheimer’s disease poses an enormous challenge to the healthcare system, and is a major obstacle for longevity. Extensive scientific research has identified soluble Aβ aggregates, collectively termed “oligomers”, as the primary neurotoxins that cause synapse dysfunction and neuronal death. Detailed structural knowledge on these Aβ oligomers would shed light on the basis of neurotoxicity and facilitate drug development to cure Alzheimer’s disease. Unfortunately, the progress on this front has been painfully slow. In this project, we propose to characterize the structure of Aβ globulomers formed by the 42-residue isoform of Aβ protein. Our preliminary studies have shown that, with electron paramagnetic resonance (EPR) spectroscopy, we were able to resolve structural heterogeneity and reveal the antiparallel architecture in Aβ oligomers. This project will build upon these preliminary studies and further tackle four specific aims. First, we will study the detailed secondary structure of Aβ42 globulomers using spin label mobility analysis at all 42 residue positions. Second, we will characterize the tertiary structure using intra-molecular distance measurements. Third, we will characterize the quaternary structure through inter-molecular distance analysis. Fourth, we will use protein structure prediction program Rosetta to model the structure of Aβ42 globulomers and cross-validate the top models using mutagenesis approaches. The field of Alzheimer’s research has suffered from a lack of accurate structural models of Aβ oligomers. Success in this project will fill this gap and provide unprecedented insights into the structures of Aβ42 oligomers. The structural knowledge on these oligomers will greatly facilitate the overall effort in understanding and treating Alzheimer’s disease and other amyloid-involved human diseases, including Parkinson’s, Huntington’s, and type 2 diabetes.

项目总结/文摘